New‐onset inflammatory arthritis after COVID ‐19 vaccination: A systematic review
International Journal of Rheumatic Diseases · 2023-02 · 26 (2) · 267-277
DOI: 10.1111/1756-185x.14482 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Rheumatic Diseases, online erschienen am 12.11.2022. Verfasst von Cheng-Che Chen und 1 weiteren Autor:innen. Beteiligte Einrichtung: College of Chinese Medicine, China Medical University, Taichung City, Taiwan. Hauptthemen laut MEDLINE: COVID-19, Arthritis. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Aim
To analyze the clinical patterns of new‐onset inflammatory arthritis after COVID‐19 vaccination among patients without pre‐existing rheumatic or autoimmune diseases.
Method
Case reports and series of new‐onset inflammatory arthritis after COVID‐19 vaccination were collected before April 2022. Clinical characteristics including diagnosis, age, gender, vaccine types, time interval between events, joint involvement (poly‐ or oligo−/monoarthritis), and laboratory data reflecting inflammatory status were sorted and P values between these parameters are calculated with independent sample Student's t test or 2 × 2 Fisher's exact test.
Results
Among 39 cases with new‐onset post‐vaccination arthritis including 25 females and 13 males (1 unknown), the most common diagnosis is adult‐onset Still's disease (AoSD, 10 cases), and the most common vaccine types are BNT162b2 (16 cases) and AZD‐1222 (or ChAdOx1‐nCoV19, 15 cases). Sub‐analysis reveals that post‐vaccination polyarthritis is more common among females ( P = .016, by 2 × 2 Fisher's exact test, compared with male patients) and older patients ( P = .006, by Student's t test). The C‐reactive protein level is significantly higher in cases with post‐vaccination inflammatory polyarthritis than oligoarthritis ( P = .029), as well as in cases with AoSD than other causes of post‐vaccination arthritis ( P = .004). However, serum level of erythrocyte sedimentation rate in patients with post‐vaccination AoSD are independent of other clinical variables in the analysis.
Conclusion
New‐onset post‐vaccination polyarthritis are more common in females and older patients. Although COVID‐19 vaccines may lead to inflammatory arthritis, the benefits of vaccination substantially outweigh the potential risks of such serious adverse effects due to their rarity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Chinese Medicine, China Medical University, Taichung City, Taiwan.
- Division of Allergy, Immunology and Rheumatology, Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan.
- Department of Traditional Chinese Medicine, Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan.
ORCID-Profile: Cheng-Che Chen, Chung-Jen Chen
Zitieren
APA
Chen, C. C., & Chen, C. J. (2023). New‐onset inflammatory arthritis after COVID ‐19 vaccination: A systematic review. International Journal of Rheumatic Diseases, 26(2), 267-277. https://doi.org/10.1111/1756-185x.14482
Vancouver
Chen CC, Chen CJ. New‐onset inflammatory arthritis after COVID ‐19 vaccination: A systematic review. International Journal of Rheumatic Diseases. 2023;26(2):267-277. doi:10.1111/1756-185x.14482
BibTeX
@article{Chen2023,
author = {Chen, Cheng-Che and Chen, Chung-Jen},
title = {New‐onset inflammatory arthritis after COVID ‐19 vaccination: A systematic review},
journal = {International Journal of Rheumatic Diseases},
year = {2023},
volume = {26},
number = {2},
pages = {267--277},
doi = {10.1111/1756-185x.14482}
}
EUVIMED